PD-L1ATTAC mice reveal the potential of targeting PD-L1 expressing cells in cancer therapy
E. Fueyo-Marcos, C. Fustero-Torre, G. Lopez, M. E. Anton, F. Al-Shahrour, O. Fernandez-Capetillo, M. Murga
The paper develops PD-L1ATTAC mice to study PD-L1-expressing cells' role in cancer and immunity, finding their elimination enhances antitumor immunity and worsens septic responses.
bioRxiv · Jul 22, 2022 · PreprintCancer Biology